Ccya Corp Co., Ltd. is a Company Limited, established on 14 Dec 2017 and registered in Suratthani, Thailand. The Company’s principal business is manufacture of pharmaceuticals, medicinal chemical products. Ccya Corp Co., Ltd. has been operating for 8 years and its current status is Active.
Profile
Company DetailsCompany record
- Legal name
- Ccya Corp Co., Ltd.
- Registration number
- 0125560033391
- Entity type
- Company Limited
- Status
- Active
- Registered date
- 14 Dec 2017
- Registered capital (THB)
- THB 1,000,000
- Industry group
- Manufacturing
- TSIC activity
- Manufacture of pharmaceuticals, medicinal chemical products
Contact DetailsRegistered contact information
- Registered address
- 81/150-151, Moo 1, Chalokrat, Bang Kung, Muang, Surat Thani 84000
- Operational address
- Locked🔒
- Website
- Locked🔒
- Telephone
- Locked🔒
People
ManagementRecorded directors and signatory
ShareholderShareholding of Ccya Corp Co., Ltd.
Ownership records and shareholder relationships require premium access.
- ✓Shareholder names and holdings
- ✓Ownership percentages and changes
Financial
Credit RatingCredit rating for Ccya Corp Co., Ltd.
Credit assessment and supporting financial indicators require premium access.
- ✓Credit rating and payment profile
- ✓Financial strength and risk indicators
Risk
Government ConnectionGovernment connection checks for Ccya Corp Co., Ltd.
Government ownership, control, and politically exposed person links require premium access.
- ✓Government ownership and control checks
- ✓Politically exposed person links
Litigation checks for Ccya Corp Co., Ltd.
Court records and material dispute intelligence require premium access.
- ✓Civil and commercial court records
- ✓Case status and material outcomes
Regulatory checks for Ccya Corp Co., Ltd.
Regulatory actions, sanctions, and compliance findings require premium access.
- ✓Regulatory actions and sanctions
- ✓Licence and compliance findings
Adverse media checks for Ccya Corp Co., Ltd.
Source-screened media coverage and reputational risk signals require premium access.
- ✓Source-screened media coverage
- ✓Material allegations and reputational signals
